RecruitingNCT03378739

Inova Cardiogenic Shock Registry (INOVA SHOCK)

Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry)

Sponsor

Inova Health Care Services

Enrollment

3,000 participants

Start Date

Jan 1, 2018

Study Type

OBSERVATIONAL

Conditions

Cardiogenic Shock

Summary

To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates. To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017. To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella). • Assess survival at three time points.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria1

Patients at the IHVI with documented Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock.

Exclusion Criteria1

Patients under the age of 18 will be excluded.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECardiogenic Shock team activation

Any patient with cardiogenic shock, whether inpatient or transferred from another facility, treated at the Inova Heart and Vascular Institute by the designated Cardiogenic Shock Team.

Locations(1)

Inova Fairfax Hospital

Falls Church, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03378739

Related Trials

Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock

NCT0734555911 locations

Characterisation of phenotYpes in aCute Heart faiLure patiEnts

NCT075088911 location

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction

NCT051684621 location

Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock

NCT051854923 locations

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

NCT044194801 location